Submission Details
| 510(k) Number | K212859 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 08, 2021 |
| Decision Date | December 20, 2021 |
| Days to Decision | 103 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K212859 is an FDA 510(k) clearance for the First Relief, a Stimulator, Nerve, Electrical, Percutaneous (pens), For Pain Relief (Class II — Special Controls, product code NHI), submitted by Dyansys, Inc. (San Mateo, US). The FDA issued a Cleared decision on December 20, 2021, 103 days after receiving the submission on September 8, 2021. This device falls under the Neurology review panel. Regulated under 21 CFR 882.5890.
| 510(k) Number | K212859 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 08, 2021 |
| Decision Date | December 20, 2021 |
| Days to Decision | 103 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | NHI — Stimulator, Nerve, Electrical, Percutaneous (pens), For Pain Relief |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 882.5890 |
| Definition | Percutaneous Electrical Nerve Stimulator (pens) Is A Device Used For The Treatment Of Pain. Unlike The Classified Transcutaneous Electrical Nerve Stimulator That Apply An Electrical Current To Electrodes On A Patient's Skin To Deliver Stimulation, A Pens Uses Electrodes That Are Placed Percutaneously To Deliver Stimulation, |